Respite last week came on the way of patients suffering from Non Alcoholic Fatty Liver Disease as a new research has clinically proven that Tocotrienols can be use to achieve a complete remission of Non Alcoholic Fatty Liver Disease, NAFLD, which hitherto had no effective treatment.
Non Alcoholic Fatty Liver Disease is a group of diseases arising from the excessive accummulation of triglycerides and other fats in liver cells. Risk factors are thought to include obesity, diabetes, hyperlipidemia, sedentary lifestyle, etc. The global prevalence is currently put at 30 per cent of the adult population or over 500 million people. The prevalence is over 90 per cent among obese diabetics.
...